文献速递细菌感染、耐药与抗菌药物医院感染防控

喹诺酮及多重耐药预示自发性细菌性腹膜炎抗生素预防失败

Quinolone and Multidrug Resistance Predicts Failure of Antibiotic Prophylaxis of Spontaneous Bacterial Peritonitis.
PubMed 文献 · Clin Infect Dis · 2020-01-01

这项前瞻性观察研究在德国三级中心纳入77例肝硬化需氟喹诺酮预防SBP的患者,基线MDRO定植率50.6%,预防期间35.1%出现新发MDRO,QR-GNB独立关联预防失败(HR 3.39)及SBP前死亡(SHR 6.47)。

要点

  • 基线MDRO定植率高达50.6%,预防期间35.1%出现新发MDRO。
  • QR-GNB独立预测预防失败(HR 3.39)及SBP前死亡(SHR 6.47)。
  • 已知MDRO患者抗生素预防SBP效果可能较差,需定期筛查。

核心结论

  • 已知MDRO患者中抗生素预防SBP效果可能较差。
  • QR-GNB独立关联预防失败(HR 3.39,P=.045)及SBP前死亡(SHR 6.47,P=.034)。

研究设计与样本

  • 前瞻性观察研究,纳入77例肝硬化需氟喹诺酮预防SBP患者,平均预防93天。
  • 在德国大型三级参考中心招募随访,基线和第30、60、90、180天行微生物与临床监测。

主要发现

  • 基线MDRO定植39例(50.6%),预防期间新发MDRO 27例(35.1%)。
  • 33例(42.9%)发生继发感染,其中MDRO感染14例(17.9%),新发/复发SBP 13例(16.9%)。
  • 随访期间30例(39.0%)死亡。
  • 有 vs 无任何MDRO(P=.009)、VRE(P=.008)、MDR-GNB(P=.016)、QR-GNB(P=.015)者预防期间SBP风险显著更高。

临床怎么用

  • 对已知MDRO患者,应重新评估氟喹诺酮预防SBP的获益。
  • 定期MDRO筛查有助于指导继发感染治疗并在选择喹诺酮耐药时重新评估预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The efficacy of antibiotic prophylaxis to prevent spontaneous bacterial peritonitis (SBP) in patients colonized with multidrug-resistant organisms (MDROs) is unknown. We evaluated the effectiveness of fluoroquinolone-based SBP prophylaxis in an era and area of frequent antibiotic resistance. METHODS: This is a prospective observational study in patients with liver cirrhosis and an indication for fluoroquinolone-based prophylaxis of SBP. Patients were recruited and followed in a large German tertiary reference center with comprehensive microbiological and clinical monitoring performed at baseline and after 30, 60, 90, and 180 days of prophylaxis. RESULTS: Overall, 77 patients received antibiotic prophylaxis for an average of 93 days. Baseline prevalence of colonization with MDROs was high (N = 39, 50.6%). At least one de novo MDRO was detected in 27 patients (35.1%) during antibiotic prophylaxis; 33 patients (42.9%) developed secondary infections, including 14 cases (17.9%) of infections with MDROs, and 13 cases (16.9%) of de novo/recurrent SBP. Thirty patients (39.0%) died during follow-up. Significantly higher risks of SBP development during antibiotic prophylaxis were observed for patients with versus without any apparent MDROs (P = .009), vancomycin-resistant enterococci (P = .008), multidrug-resistant gram-negative bacteria (P = .016), or quinolone-resistant gram-negative bacteria (QR-GNB) (P = .015). In competing risk analysis, QR-GNB were independently associated with prophylaxis failure (hazard ratio, 3.39; P = .045) and infections with QR-GNB were independently associated with death before SBP (subdistribution hazard risk, 6.47; P = .034). CONCLUSIONS: Antibiotic prophylaxis of SBP appears to be less efficient in patients with known MDROs. Regular MDRO screening seems to be useful to tailor treatment of secondary infections and re-evaluate antibiotic prophylaxis in case of selection of quinolone resistance.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mücke MM, Mayer A, Kessel J, et al. Quinolone and Multidrug Resistance Predicts Failure of Antibiotic Prophylaxis of Spontaneous Bacterial Peritonitis. Clin Infect Dis. 2020. PMID: 31228250. doi:10.1093/cid/ciz540

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。